Corporate News 16-Feb-23
USFDA issues EIR for Piramal Pharma's Lexington facility
Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR) for the company's manufacturing facility located at Lexington (Kentucky, USA) and the inspection has now been successfully closed by the USFDA.
Previous News
Piramal Pharma reports consolidated net profit of Rs 5.02 crore in the September 2023 quarter
( Results - Announcements 28-Oct-23 07:38 )
Piramal Pharma launches Chlorpromazine Hydrochloride in US
( Hot Pursuit - 23-Jan-25 09:38 )
CARE Ratings Ltd leads gainers in 'A' group
( Hot Pursuit - 24-Oct-24 12:00 )
Prism Johnson Ltd leads gainers in 'A' group
( Hot Pursuit - 13-Jan-25 12:00 )
Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility
( Corporate News - 30-Sep-24 18:48 )
Volumes spurt at Piramal Pharma Ltd counter
( Hot Pursuit - 13-Jan-25 14:30 )
Piramal Pharma hits life high on reporting multi-fold jump in Q2 PAT
( Hot Pursuit - 24-Oct-24 12:32 )
Piramal Pharma to conduct board meeting
( Corporate News - 29-Jul-23 17:22 )
Piramal Pharma to conduct AGM
( Corporate News - 14-Jun-25 14:54 )
Piramal Pharma's Aurora unit completes USFDA inspection
( Corporate News - 02-Jun-25 16:21 )
Piramal Pharma's Lexington facility completes USFDA inspection
( Corporate News - 23-May-24 10:49 )
Other Stories
LMW schedules board meeting
03-Jul-25 09:15
Julien Agro Infratech announces board meeting date
03-Jul-25 09:15
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
03-Jul-25 09:15
Shriram Asset Mgt. Company schedules AGM
03-Jul-25 09:14
Ideaforge Technology to convene AGM
03-Jul-25 09:14
D-Link (India) to announce Quarterly Result
03-Jul-25 09:14
Tuni Textile Mills to conduct board meeting
03-Jul-25 09:14
Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
03-Jul-25 09:12
Shakti Pumps launches QIP issue
03-Jul-25 09:08
Jai Mata Glass to conduct board meeting
02-Jul-25 19:12
Back
Top
